EDGAR Filing Documents for 0001047469-17-003553

Form 424B2 - Prospectus [Rule 424(b)(2)]:

SEC Accession No. 0001047469-17-003553

Filing Date

2017-05-23

Accepted

2017-05-22 19:54:38

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B2	a2232240z424b2.htm	424B2	814957
2	G44098.JPG	g44098.jpg	GRAPHIC	8336
3	G922024.JPG	g922024.jpg	GRAPHIC	33092
4	G4873.JPG	g4873.jpg	GRAPHIC	25393
	Complete submission text file	0001047469-17-003553.txt		908455

Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406

Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 6108166640

Nabriva Therapeutics Plc (Filer) CIK: 0001703287 (see all company filings)